Fresenius | FRE - 销售和管理费用





销售和管理费用 更改 日
Akzo Nobel EUR 833M 29M 2026-06
Alcon AG USD 964M 82M 2026-06
AstraZeneca USD 5.8B 735M 2026-06
BASF EUR 2.28B 156M 2026-06
Bayer EUR 3.96B 267M 2026-06
Beiersdorf EUR 271M 51M 2025-12
DaVita Healthcare Partners USD 423.46M 1.54M 2026-06
Demant DKK 7.09B 1B 2026-06
E.ON EUR -1.71B 3.63B 2025-06
Essilor EUR 5.75B 139M 2026-06
Fresenius EUR 760M 17M 2026-06
Fresenius Medical Care EUR 736.01M 12.99M 2026-06
Getinge SEK 2.65B 452M 2024-12
Givaudan CHF 561M 25M 2025-12
GlaxoSmithKline GBP 2.19B 75M 2026-06
GN Store Nord DKK 805M 42M 2026-06
GRIFOLS EUR 289M 8M 2026-06
Hikma Pharmaceutical USD 288M 149M 2025-12
Merck EUR 1.57B 49M 2026-06
Novartis USD 3.24B 101M 2026-06
Philips EUR 1.21B 23M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
RWE EUR 690M 84M 2025-03
Sanofi EUR 2.63B 307M 2026-06
Smith & Nephew USD 1.45B 29M 2026-06